Diabetic kidney disease update: Pathogenesis and treatment overview for clinicians

Diabetes mellitus is a common cause of chronic kidney disease that progresses to end-stage renal disease (ESRD). Albuminuria (proteinuria) is an early manifestation of diabetic kidney disease (DKD). Although the hemodynamic alterations that occur in diabetics seem the underlying mechanism, others such as metabolic, inflammatory, and hypoxia have a role in DKD pathophysiology. Despite the proven beneficial effects of angiotensin-converting enzyme inhibitors and renin–angiotensin II–aldosterone receptor blockades in proteinuria improvement, their effect to prevent the DKD and to modify its progression to ESRD is not clear enough. New agents such as SLGT2 and autophagy inhibitors and anti-inflammatory are promising agents that may improve proteinuria and inhibit DKD progression. Pathophysiology and new strategies in DKD therapy updates will be reviewed.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Diabetic kidney disease update: Pathogenesis and treatment overview for clinicians ; volume:04 ; number:03 ; year:2021 ; pages:107-114
Journal of diabetes & endocrine practice ; 04, Heft 03 (2021), 107-114

Contributor
Habas, Elmukhtar
Elzouki, Abdel-Naser

DOI
10.4103/jdep.jdep_39_21
URN
urn:nbn:de:101:1-2022101004352465534750
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

  • Habas, Elmukhtar
  • Elzouki, Abdel-Naser

Other Objects (12)